EMILEE TEHRANI: Open Payments
NPI 1073042024 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,521 in 72 payments from 19 companies in 2025. Trend: 2023 $879 · 2024 $1,699 · 2025 $1,521
Food & beverage: $1,521
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $300 |
| GlaxoSmithKline, LLC. | 20 | $228 |
| Regeneron Healthcare Solutions, Inc. | 5 | $184 |
| Galderma Laboratories, L.P. | 2 | $107 |
| Viatris Specialty LLC | 5 | $92 |
| Amgen Inc. | 4 | $87 |
| GENZYME CORPORATION | 3 | $78 |
| Philips North America LLC | 3 | $51 |
| Electromed, Inc. | 3 | $47 |
| Baxter Healthcare | 1 | $46 |
Products named: DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, AIRSUPRA, YUPELRI, NUCALA, FASENRA, Vest Therapy Und.
Industry payments across IN — which companies pay providers there.
